Literature DB >> 27732798

Targeted Protein Degradation by Small Molecules.

Daniel P Bondeson1, Craig M Crews1.   

Abstract

Protein homeostasis networks are highly regulated systems responsible for maintaining the health and productivity of cells. Whereas therapeutics have been developed to disrupt protein homeostasis, more recently identified techniques have been used to repurpose homeostatic networks to effect degradation of disease-relevant proteins. Here, we review recent advances in the use of small molecules to degrade proteins in a selective manner. First, we highlight all-small-molecule techniques with direct clinical application. Second, we describe techniques that may find broader acceptance in the biomedical research community that require little or no synthetic chemistry. In addition to serving as innovative research tools, these new approaches to control intracellular protein levels offer the potential to develop novel therapeutics targeting proteins that are not currently pharmaceutically vulnerable.

Entities:  

Keywords:  IMiDs; PROTACs; chemical knockdown; protein degradation; ubiquitin proteasome system

Mesh:

Substances:

Year:  2016        PMID: 27732798      PMCID: PMC5586045          DOI: 10.1146/annurev-pharmtox-010715-103507

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  112 in total

Review 1.  The evolution of thalidomide and its IMiD derivatives as anticancer agents.

Authors:  J Blake Bartlett; Keith Dredge; Angus G Dalgleish
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

2.  The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation.

Authors:  Eric S Fischer; Andrea Scrima; Kerstin Böhm; Syota Matsumoto; Gondichatnahalli M Lingaraju; Mahamadou Faty; Takeshi Yasuda; Simone Cavadini; Mitsuo Wakasugi; Fumio Hanaoka; Shigenori Iwai; Heinz Gut; Kaoru Sugasawa; Nicolas H Thomä
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

3.  Detection of secondary binding sites in proteins using fragment screening.

Authors:  R Frederick Ludlow; Marcel L Verdonk; Harpreet K Saini; Ian J Tickle; Harren Jhoti
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-11       Impact factor: 11.205

4.  Inhibitor mediated protein degradation.

Authors:  Marcus J C Long; Deviprasad R Gollapalli; Lizbeth Hedstrom
Journal:  Chem Biol       Date:  2012-05-25

5.  Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling.

Authors:  Rory T Coffey; Yuntao Shi; Marcus J C Long; Michael T Marr; Lizbeth Hedstrom
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

6.  AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo.

Authors:  Sarah A Loddick; Sarah J Ross; Andrew G Thomason; David M Robinson; Graeme E Walker; Tom P J Dunkley; Sandra R Brave; Nicola Broadbent; Natalie C Stratton; Dawn Trueman; Elizabeth Mouchet; Fadhel S Shaheen; Vivien N Jacobs; Marie Cumberbatch; Joanne Wilson; Rhys D O Jones; Robert H Bradbury; Alfred Rabow; Luke Gaughan; Chris Womack; Simon T Barry; Craig N Robson; Susan E Critchlow; Stephen R Wedge; A Nigel Brooks
Journal:  Mol Cancer Ther       Date:  2013-07-16       Impact factor: 6.261

Review 7.  Regulation mechanisms and signaling pathways of autophagy.

Authors:  Congcong He; Daniel J Klionsky
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

8.  Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.

Authors:  Rebekka K Schneider; Vera Ademà; Dirk Heckl; Marcus Järås; Mar Mallo; Allegra M Lord; Lisa P Chu; Marie E McConkey; Rafael Kramann; Ann Mullally; Rafael Bejar; Francesc Solé; Benjamin L Ebert
Journal:  Cancer Cell       Date:  2014-09-18       Impact factor: 31.743

9.  CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.

Authors:  Patrick R Hagner; Hon-Wah Man; Celia Fontanillo; Maria Wang; Suzana Couto; Mike Breider; Chad Bjorklund; Courtney G Havens; Gang Lu; Emily Rychak; Heather Raymon; Rama Krishna Narla; Leo Barnes; Gody Khambatta; Hsiling Chiu; Jolanta Kosek; Jian Kang; Michael D Amantangelo; Michelle Waldman; Antonia Lopez-Girona; Ti Cai; Michael Pourdehnad; Matthew Trotter; Thomas O Daniel; Peter H Schafer; Anke Klippel; Anjan Thakurta; Rajesh Chopra; Anita K Gandhi
Journal:  Blood       Date:  2015-05-22       Impact factor: 22.113

10.  Conditional Degradation of Plasmodium Calcineurin Reveals Functions in Parasite Colonization of both Host and Vector.

Authors:  Nisha Philip; Andrew P Waters
Journal:  Cell Host Microbe       Date:  2015-06-25       Impact factor: 21.023

View more
  45 in total

1.  Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).

Authors:  Caroline M Robb; Jacob I Contreras; Smit Kour; Margaret A Taylor; Mohammad Abid; Yogesh A Sonawane; Muhammad Zahid; Daryl J Murry; Amarnath Natarajan; Sandeep Rana
Journal:  Chem Commun (Camb)       Date:  2017-07-04       Impact factor: 6.222

2.  "Mallostery"-ligand-dependent protein misfolding enables physiological regulation by ERAD.

Authors:  Margaret A Wangeline; Randolph Y Hampton
Journal:  J Biol Chem       Date:  2018-07-17       Impact factor: 5.157

Review 3.  Chromatin dynamics underlying latent responses to xenobiotics.

Authors:  Jonathan Moggs; Rémi Terranova
Journal:  Toxicol Res (Camb)       Date:  2018-02-28       Impact factor: 3.524

Review 4.  Targeted Protein Degradation: from Chemical Biology to Drug Discovery.

Authors:  Philipp M Cromm; Craig M Crews
Journal:  Cell Chem Biol       Date:  2017-06-22       Impact factor: 8.116

Review 5.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

6.  Basis for metabolite-dependent Cullin-RING ligase deneddylation by the COP9 signalosome.

Authors:  Hong Lin; Xiaozhe Zhang; Li Liu; Qiuyu Fu; Chuanlong Zang; Yan Ding; Yang Su; Zhixue Xu; Sining He; Xiaoli Yang; Xiayun Wei; Haibin Mao; Yasong Cui; Yi Wei; Chuanzheng Zhou; Lilin Du; Niu Huang; Ning Zheng; Tao Wang; Feng Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-11       Impact factor: 11.205

7.  A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo.

Authors:  Longchuan Bai; Haibin Zhou; Renqi Xu; Yujun Zhao; Krishnapriya Chinnaswamy; Donna McEachern; Jianyong Chen; Chao-Yie Yang; Zhaomin Liu; Mi Wang; Liu Liu; Hui Jiang; Bo Wen; Praveen Kumar; Jennifer L Meagher; Duxin Sun; Jeanne A Stuckey; Shaomeng Wang
Journal:  Cancer Cell       Date:  2019-11-11       Impact factor: 31.743

8.  Getting a handle on chemical probes of chomatin readers.

Authors:  Jarod M Waybright; Lindsey I James
Journal:  Future Med Chem       Date:  2020-01-10       Impact factor: 3.808

9.  Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.

Authors:  Dirksen E Bussiere; Lili Xie; Honnappa Srinivas; Wei Shu; Ashley Burke; Celine Be; Junping Zhao; Adarsh Godbole; Dan King; Rajeshri G Karki; Viktor Hornak; Fangmin Xu; Jennifer Cobb; Nathalie Carte; Andreas O Frank; Alexandra Frommlet; Patrick Graff; Mark Knapp; Aleem Fazal; Barun Okram; Songchun Jiang; Pierre-Yves Michellys; Rohan Beckwith; Hans Voshol; Christian Wiesmann; Jonathan M Solomon; Joshiawa Paulk
Journal:  Nat Chem Biol       Date:  2019-12-09       Impact factor: 15.040

10.  Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.

Authors:  Haibin Zhou; Longchuan Bai; Renqi Xu; Yujun Zhao; Jianyong Chen; Donna McEachern; Krishnapriya Chinnaswamy; Bo Wen; Lipeng Dai; Praveen Kumar; Chao-Yie Yang; Zhaomin Liu; Mi Wang; Liu Liu; Jennifer L Meagher; Han Yi; Duxin Sun; Jeanne A Stuckey; Shaomeng Wang
Journal:  J Med Chem       Date:  2019-12-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.